CLINICAL_TRIALS
trial_result
· 2013-12-03
Clinical Trial Update: Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2) [Phase 1]
Summary
Merck conducted a Phase 1 clinical trial evaluating continuous glucose monitoring in participants with Type 2 diabetes mellitus. The study has completed, and re…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2013-12-03